Protagonist Stock 120%, Fund Outlook and Exit Signals
A hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
Looking for ways to get cash fast when unemployed? Act now to discover the best opportunities for immediate income!
20,927 articlesA hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
DTCC’s real-world asset push is reshaping the institutional crypto stack. On one side lies Canton Network’s private-r...
Parents often ask, when should kids cell enter the family budget? This guide walks you through costs, plan options, a...
A DTCC update effective March 2, 2026 unlocks post-trade routing of institutional volumes to the XRP Ledger, as Rippl...
Regulators signal a spring decision to move perpetual Bitcoin futures onto U.S. exchanges. The shift could reshape bi...
Aave Labs unveiled a multi-layered security framework for its V4 release, backed by a $1.5 million audit program. The...
As markets swing in early 2026, many investors pay active fees for funds that closely track benchmarks. Here’s a fast...
Novo Nordisk faces intense pressure in the fast-growing obesity treatment space. This article dives into whether this...
Bitcoin steadies around the mid-50s as XRP, Solana, and PEPE push higher on evolving policy signals and renewed inves...
Aave CEO Stani Kulechov unveiled a framework to speed up DAO decisions, following a governance dispute that saw BGD L...
Binance has filed a defamation lawsuit against the Wall Street Journal in SDNY after a February report alleged sancti...
Leveraged ETFs like TQQQ and QLD promise amplified Nasdaq-100 exposure, but they come with unique risks and timing re...